Adamis Pharmaceuticals | Attività Correnti



Current Assets Cambiamento Data
Adma Biologics USD 331.41M 13.22M 2024-12
Cipla INR 232.89B 23.43B 2025-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 106M 8.83M 2024-12
CSL USD 11.31B 540M 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
Grifols EUR 5.73B 404.28M 2024-12
Merck USD 35.5B 3.28B 2025-03
Pfizer USD 45.86B 4.5B 2025-03
RedHill Biopharma USD 15.7M 3K 2024-06



Adamis Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.